908 Devices Inc. (MASS): Price and Financial Metrics
GET POWR RATINGS... FREE!
MASS Stock Price Chart Interactive Chart >
MASS Price/Volume Stats
|Current price||$35.86||52-week high||$79.60|
|Prev. close||$36.94||52-week low||$29.20|
|Day high||$37.39||Avg. volume||290,648|
|50-day MA||$33.71||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||991.49M|
908 Devices Inc. (MASS) Company Bio
908 Devices, Inc. develops measurement devices for chemical and biochemical analysis. It develops its products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.
Most Popular Stories View All
MASS Latest News Stream
|Loading, please wait...|
MASS Latest Social Stream
View Full MASS Social Stream
Latest MASS News From Around the Web
Below are the latest news stories about 908 Devices Inc that investors may wish to consider to help them evaluate MASS as an investment opportunity.
Joseph Griffith Iv, Chief Financial Officer at 908 Devices (NASDAQ:MASS), made a large buy and sell of company shares on September 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 8, Joseph Griffith Iv bought 49,898 908 Devices shares at prices ranging from $0.53 to $0.96 per share, for a total of $28,082. They then sold their shares on the same day in the open market at prices ranging from $36.66 to $39.0
Multiple insiders secured a larger position in 908 Devices Inc. ( NASDAQ:MASS ) shares over the last 12 months. This is...
In this article, we will be discussing 8 best stocks to buy according to billionaire Nicholas J. Pritzker based on his hedge fund’s Q1 portfolio. To skip our detailed analysis of Nicholas J. Pritzker’s hedge fund returns, investment philosophy, and history, you can click to skip ahead to 4 Best Stocks to Buy According to […]
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended June 30, 2021. I am incredibly proud of our teams progress this quarter as we continue to execute on our growth strategy. We have made important strides across our business and are looking forward to continuing this momentum into the second half of the year, said Kevin J. Knop
BOSTON--(BUSINESS WIRE)--908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the forthcoming appointment of six new individuals to its Scientific Advisory Board (SAB), including Prof. Ileana Cristea, Prof. Jennifer E. Van Eyk, Prof. Anne-Claude Gingras, Prof. Jesper Olsen, Prof. Renã Robinson, and Prof. John Yates. The new SAB members join the boards co-chairs, Christopher D. Brown, CTO 908 Device
MASS Price Returns